( Rutgers University ) Researchers led by Rutgers' Samuel Gunderson have developed a novel gene silencing platform with very significant improvements over existing RNAi approaches. This may enable the development and discovery of a new class of drugs to treat a wide array of diseases. Critical to the technology is the approach this team took to specifically target RNA biosynthesis. The research ...
More...
More...
